See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

Bio

Generated by
Topline AI
Robert M Levande is a seasoned executive with 18 years of experience in investment banking, entrepreneurship, and leadership roles. He has a strong background in Mergers and Acquisitions, Strategy, and Business Development. Levande has held senior positions at MDB Capital Group, LLC, Pulse Biosciences, Inc., and The Arena Group Holdings, Inc. He also serves on the boards of Orthovita, Inc. and VirnetX Holding Corp. Levande holds an MBA from Columbia University and a BS in Economics from the University of Pennsylvania - The Wharton School. As a seasoned executive, Levande has a proven track record of driving growth, strategy, and deal-making in various industries. His expertise spans Mergers and Acquisitions, Private Placements, Securities, and Business Development. With his strong network and leadership skills, Levande is well-positioned to drive success in his next endeavor.

Experience

    • Senior Managing Director
      • Jun 2003 - Jan 2022
      • New York City

      MDB is an investment banking firm specialized in creating, building, and financing start-up companies that possess unique technology that can meaningfully advance the science in their field.

    • Co-Founder and Chairman of the Board
      • Mar 2014 - Nov 2017

      Pulse Biosciences (Nasdaq: PLSE) is a medical device company which is developing its unique Nanosecond Pulsed Field Ablation technology to treat atrial fibrillation and other medical conditions.

    • Board Member
      • Aug 2008 - Jul 2017

      The Arena Group (NYSE: AREN) is an expert-driven, group media network. Its platform provides value to independent publishers via broader distribution, greater engagement for their content and community, improved monetization through efficient advertising partnerships and membership programs, and tools to better manage their audience and growth.

    • Board Member
      • May 2000 - Jul 2007

      Orthovita was a Nasdaq-listed biomaterials company with proprietary technologies for the development and commercialization of synthetic, biologically active, tissue engineering products for orthopedic and neurosurgical applications

    • Co-Founder
      • 2005 - 2007

      VirnetX Holding Corporation (NYSE: VHC) broard patent portfolio covers technology that allows for secure across-the-network verification using its unique combination of cryptographic certified domain names, computer network addresses and public keys.

Education

  • Columbia University
    MBA, Finance
  • University of Pennsylvania - The Wharton School
    BS, Economics

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Investment Banking”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Social Profiles

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles